SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (4690)7/2/1998 12:58:00 AM
From: billkirn  Read Replies (1) of 6136
 
Izzy: Yes. These prices are a great value. That said, the buying opportunity could get better.
I suggest to everyone I know, buy this stock now. In 2 years we should review our abilities to predict the value of a company and this one will make us seem pretty intelligent. So don't be afraid to look stupid in the short term!
Once I can get a better understanding of the people at Immune Response and their business sense, I might add them to the page..
Over the last few months it has been difficult to feel enthusiasm for these companies. The whole biotech industry is in a funk and very little appreciation and recognition of prospects has been reflected in the current stock prices. This could change in a moment and it probably will in a few months.
It is time to let the business work out, have a little trust in the leadership and relax for awhile.
Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext